These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29989102)

  • 21. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics.
    Lu DY; Qu RX; Lu TR; Wu HY
    Rev Recent Clin Trials; 2017; 12(2):101-110. PubMed ID: 28190390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational Bioinformatics: Integrating Electronic Health Record and Omics Data.
    Kim D; Kim JH; Moore JH
    Pac Symp Biocomput; 2021; 26():356-359. PubMed ID: 33691034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational Bioinformatics for Human Reproductive Biology Research: Examples, Opportunities and Challenges for a Future Reproductive Medicine.
    Liu K; Zhang Y; Martin C; Ma X; Shen B
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics Methods and Tools to Advance Clinical Care. Findings from the Yearbook 2015 Section on Bioinformatics and Translational Informatics.
    Soualmia LF; Lecroq T
    Yearb Med Inform; 2015 Aug; 10(1):170-3. PubMed ID: 26293864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International Conference on Intelligent Biology and Medicine (ICIBM) 2018: bioinformatics towards translational applications.
    Liu X; Xie L; Wu Z; Wang K; Zhao Z; Ruan J; Zhi D
    BMC Bioinformatics; 2018 Dec; 19(Suppl 17):492. PubMed ID: 30591012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five critical elements to ensure the precision medicine.
    Chen C; He M; Zhu Y; Shi L; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):313-8. PubMed ID: 25920354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The forthcoming era of precision medicine.
    Gamulin S
    Acta Med Acad; 2016 Nov; 45(2):152-157. PubMed ID: 28000491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
    Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
    Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
    Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
    Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Education, collaboration, and innovation: intelligent biology and medicine in the era of big data.
    Ruan J; Jin V; Huang Y; Xu H; Edwards JS; Chen Y; Zhao Z
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S1. PubMed ID: 26099197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing, analysing, and integrating big data in medical bioinformatics: open problems and future perspectives.
    Merelli I; Pérez-Sánchez H; Gesing S; D'Agostino D
    Biomed Res Int; 2014; 2014():134023. PubMed ID: 25254202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational Bioinformatics to Enable Precision Medicine for All: Elevating Equity across Molecular, Clinical, and Digital Realms.
    Tang A; Woldemariam S; Roger J; Sirota M
    Yearb Med Inform; 2022 Aug; 31(1):106-115. PubMed ID: 36463867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Data-driven microbiota biomarker discovery for personalized drug therapy of cardiovascular disease.
    Shen L; Shen K; Bai J; Wang J; Singla RK; Shen B
    Pharmacol Res; 2020 Nov; 161():105225. PubMed ID: 33007417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
    Yang L; Feng S; Yang Y
    Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connecting the dots in translational bioinformatics: TBC 2014 collection.
    Kim JH
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):I1. PubMed ID: 26043981
    [No Abstract]   [Full Text] [Related]  

  • 37. Computational Modelling of Liver Metabolism and its Applications in Research and the Clinics.
    Cvitanović Tomaš T; Moškon M; Mraz M; Rozman D
    Acta Chim Slov; 2018 Jun; 65(2):253-265. PubMed ID: 29993093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovation Management? Orienting Sepsis R&D and Technology Transfer Towards Stratified Medicine.
    Özdemir V; Hekim N
    EBioMedicine; 2016 Apr; 6():8-9. PubMed ID: 27211534
    [No Abstract]   [Full Text] [Related]  

  • 39. From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
    Roca J; Cano I; Gomez-Cabrero D; Tegnér J
    Methods Mol Biol; 2016; 1386():283-303. PubMed ID: 26677188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
    Wang P; Lv L
    Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.